{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:51:19Z","timestamp":1789419079704,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81760284"],"award-info":[{"award-number":["No.81760284"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO. 82060465"],"award-info":[{"award-number":["NO. 82060465"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Foundation of Jiangxi Province","award":["No. 20192BCD40003"],"award-info":[{"award-number":["No. 20192BCD40003"]}]},{"name":"Natural Foundation of Jiangxi Province","award":["NO. 20212ACB206023"],"award-info":[{"award-number":["NO. 20212ACB206023"]}]},{"name":"Science Foundation of Jiangxi Provincial Education Department","award":["No. GJJ150231"],"award-info":[{"award-number":["No. GJJ150231"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00432-023-04618-0","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:03:06Z","timestamp":1677283386000},"page":"6931-6941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer"],"prefix":"10.1007","volume":"149","author":[{"given":"Yuanqiao","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongbing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"issue":"1","key":"4618_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-020-00903-4","volume":"13","author":"NG Azizian","year":"2020","unstructured":"Azizian NG, Li Y (2020) XPO1-dependent nuclear export as a target for cancer therapy. J Hematol Oncol 13(1):61","journal-title":"J Hematol Oncol"},{"issue":"2","key":"4618_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","volume":"27","author":"MC Bleeker","year":"2009","unstructured":"Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ (2009) Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 27(2):141\u2013150","journal-title":"World J Urol"},{"key":"4618_CR3","doi-asserted-by":"publisher","first-page":"7428010","DOI":"10.1177\/17588359221127254","volume":"14","author":"J Chadha","year":"2022","unstructured":"Chadha J, Chahoud J, Spiess PE (2022) An update on treatment of penile cancer. Ther Adv Med Oncol 14:7428010","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"4618_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.14348\/molcells.2016.2350","volume":"39","author":"SY Cho","year":"2016","unstructured":"Cho SY, Kang W, Han JY, Min S, Kang J, Lee A, Kwon JY, Lee C, Park H (2016) An integrative approach to precision cancer medicine using patient-derived xenografts. Mol Cells 39(2):77\u201386","journal-title":"Mol Cells"},{"issue":"1","key":"4618_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ygyno.2019.11.020","volume":"156","author":"A Collins","year":"2020","unstructured":"Collins A, Miles GJ, Wood J, MacFarlane M, Pritchard C, Moss E (2020) Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer. Gynecol Oncol 156(1):251\u2013259","journal-title":"Gynecol Oncol"},{"issue":"5","key":"4618_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.21037\/tau.2017.05.19","volume":"6","author":"A Douglawi","year":"2017","unstructured":"Douglawi A, Masterson TA (2017) Updates on the epidemiology and risk factors for penile cancer. Translat Androl Urol 6(5):785\u2013790","journal-title":"Translat Androl Urol"},{"key":"4618_CR7","doi-asserted-by":"crossref","unstructured":"Duffy MJ, Synnott NC, Crown J (2017) Mutant p53 as a target for cancer treatment. Eur J Cancer (Oxford, England: 1990), 83:258\u2013265","DOI":"10.1016\/j.ejca.2017.06.023"},{"issue":"4","key":"4618_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molmed.2017.02.001","volume":"23","author":"AG Georgakilas","year":"2017","unstructured":"Georgakilas AG, Martin OA, Bonner WM (2017) p21: A Two-Faced Genome Guardian. Trends Mol Med 23(4):310\u2013319","journal-title":"Trends Mol Med"},{"issue":"26","key":"4618_CR9","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1200\/JCO.2016.67.6346","volume":"34","author":"MM Gounder","year":"2016","unstructured":"Gounder MM, Zer A, Tap WD, Salah S, Dickson MA, Gupta AA, Keohan ML, Loong HH, D\u2019Angelo SP, Baker S, Condy M, Nyquist-Schultz K, Tanner L, Erinjeri JP, Jasmine FH, Friedlander S, Carlson R, Unger TJ, Saint-Martin JR, Rashal T, Ellis J, Kauffman M, Shacham S, Schwartz GK, Abdul Razak AR (2016) Phase IB Study of Selinexor, a first-in-class inhibitor of nuclear export, in patients with advanced refractory bone or soft tissue sarcoma. J Clin Oncol 34(26):3166\u20133174","journal-title":"J Clin Oncol"},{"key":"4618_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-014-0085-1","volume":"7","author":"GL Gravina","year":"2014","unstructured":"Gravina GL, Senapedis W, McCauley D, Baloglu E, Shacham S, Festuccia C (2014) Nucleo-cytoplasmic transport as a therapeutic target of cancer. J Hematol Oncol 7:85","journal-title":"J Hematol Oncol"},{"issue":"9","key":"4618_CR11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinsk\u00e1 E, Byrne AT, Caldas C, Clarke RB, de Jong S, Jonkers J, M\u00e6landsmo GM, Roman-Roman S, Seoane J, Trusolino L, Villanueva A (2014) Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov 4(9):998\u20131013","journal-title":"Cancer Discov"},{"issue":"1","key":"4618_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4143\/crt.2017.307","volume":"50","author":"J Jung","year":"2018","unstructured":"Jung J, Seol HS, Chang S (2018) The generation and application of patient-derived xenograft model for cancer research. Cancer Res Treat 50(1):1\u201310","journal-title":"Cancer Res Treat"},{"key":"4618_CR13","doi-asserted-by":"crossref","unstructured":"Kyrylkova K, Kyryachenko S, Leid M, Kioussi C (2012) Detection of apoptosis by TUNEL assay. Methods Mol Biol (Clifton, N.J.), 887:41\u201347","DOI":"10.1007\/978-1-61779-860-3_5"},{"issue":"1","key":"4618_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13045-017-0470-7","volume":"10","author":"Y Lai","year":"2017","unstructured":"Lai Y, Wei X, Lin S, Qin L, Cheng L, Li P (2017) Current status and perspectives of patient-derived xenograft models in cancer research. J Hematol Oncol 10(1):106","journal-title":"J Hematol Oncol"},{"issue":"3","key":"4618_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/1759-7714.12181","volume":"6","author":"Y Ma","year":"2015","unstructured":"Ma Y, Fan M, Dai L, Kang X, Liu Y, Sun Y, Xiong H, Liang Z, Yan W, Chen K (2015) Expression of p63 and CK5\/6 in early-stage lung squamous cell carcinoma is not only an early diagnostic indicator but also correlates with a good prognosis. Thoracic Cancer 6(3):288\u2013295","journal-title":"Thoracic Cancer"},{"key":"4618_CR16","doi-asserted-by":"publisher","first-page":"6405","DOI":"10.2147\/OTT.S227166","volume":"13","author":"P Malandrakis","year":"2020","unstructured":"Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Terpos E (2020) Clinical utility of selinexor\/dexamethasone in patients with relapsed or refractory multiple myeloma: a review of current evidence and patient selection. OncoTargets Therapy 13:6405\u20136416","journal-title":"OncoTargets Therapy"},{"issue":"9","key":"4618_CR17","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3390\/pharmaceutics13091522","volume":"13","author":"AL Marretta","year":"2021","unstructured":"Marretta AL, Di Lorenzo G, Ribera D, Cannella L, von Arx C, Bracigliano A, Clemente O, Tafuto R, Pizzolorusso A, Tafuto S (2021) Selinexor and the selective inhibition of nuclear export: a new perspective on the treatment of sarcomas and other solid and non-solid tumors. Pharmaceutics 13(9):1522","journal-title":"Pharmaceutics"},{"issue":"9","key":"4618_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/cdd.2011.81","volume":"18","author":"G Melino","year":"2011","unstructured":"Melino G (2011) p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Different 18(9):1487\u20131499","journal-title":"Cell Death Different"},{"key":"4618_CR19","doi-asserted-by":"crossref","unstructured":"Nguyen R, Wang H, Sun M, Lee DG, Peng J, Thiele CJ (2022) Combining selinexor with alisertib to target the p53 pathway in neuroblastoma. Neoplasia (New York, N.Y.), 26:100776","DOI":"10.1016\/j.neo.2022.100776"},{"issue":"1","key":"4618_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","volume":"20","author":"TB Olesen","year":"2019","unstructured":"Olesen TB, Sand FL, Rasmussen CL, Albieri V, Toft BG, Norrild B, Munk C, Kj\u00e6r SK (2019) Prevalence of human papillomavirus DNA and p16 in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. The Lancet Oncol 20(1):145\u2013158","journal-title":"The Lancet Oncol"},{"issue":"1","key":"4618_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.18632\/oncotarget.439","volume":"3","author":"N Pabla","year":"2012","unstructured":"Pabla N, Dong Z (2012) Curtailing side effects in chemotherapy: a tale of PKC\u03b4 in cisplatin treatment. Oncotarget 3(1):107\u2013111","journal-title":"Oncotarget"},{"issue":"10","key":"4618_CR22","doi-asserted-by":"publisher","first-page":"101179","DOI":"10.1016\/j.tranon.2021.101179","volume":"14","author":"JC Rosen","year":"2021","unstructured":"Rosen JC, Weiss J, Pham NA, Li Q, Martins-Filho SN, Wang Y, Tsao MS, Moghal N (2021) Antitumor efficacy of XPO1 inhibitor Selinexor in KRAS-mutant lung adenocarcinoma patient-derived xenografts. Translat Oncol 14(10):101179","journal-title":"Translat Oncol"},{"issue":"1","key":"4618_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/modpathol.2013.125","volume":"27","author":"R Seiler","year":"2014","unstructured":"Seiler R, Thalmann GN, Rotzer D, Perren A, Fleischmann A (2014) CCND1\/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response. Modern Pathol 27(1):87\u201395","journal-title":"Modern Pathol"},{"issue":"8","key":"4618_CR24","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/ijc.32662","volume":"146","author":"J Shi","year":"2020","unstructured":"Shi J, Li Y, Jia R, Fan X (2020) The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance. Int J Cancer 146(8):2078\u20132088","journal-title":"Int J Cancer"},{"key":"4618_CR25","unstructured":"Stratton KL, Culkin DJ (2016) A contemporary review of HPV and penile cancer. Oncology (Williston Park, N.Y.), 30(3):245\u2013249"},{"issue":"1","key":"4618_CR26","doi-asserted-by":"publisher","first-page":"12248","DOI":"10.1038\/s41598-018-30686-1","volume":"8","author":"VV Subhash","year":"2018","unstructured":"Subhash VV, Yeo MS, Wang L, Tan SH, Wong FY, Thuya WL, Tan WL, Peethala PC, Soe MY, Tan DSP, Padmanabhan N, Baloglu E, Shacham S, Tan P, Koeffler HP, Yong WP (2018) Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor. Scient Rep 8(1):12248","journal-title":"Scient Rep"},{"issue":"2","key":"4618_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2020.05.033","volume":"78","author":"A Thomas","year":"2020","unstructured":"Thomas A, Vanthoor J, Himmelreich U, Cawthorne C, Deroose CM, Gsell W, Spans L, Rizzotto L, Leucci E, Van Rompuy AS, Muneer A, Albersen M (2020) European reference network for rare urogenital diseases and complex conditions (eUROGEN). Establishment, characterization, and imaging of a first platinum-resistant penile cancer patient-derived xenograft in nude mice: A eUROGEN Project. Eur Uroly 78(2):294\u2013296","journal-title":"Eur Uroly"},{"issue":"1","key":"4618_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-021-00246-5","volume":"7","author":"A Thomas","year":"2021","unstructured":"Thomas A, Necchi A, Muneer A, Tobias-Machado M, Tran ATH, Van Rompuy AS, Spiess PE, Albersen M (2021) Penile cancer. Nat Rev Dis Prim 7(1):11","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"4618_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","volume":"13","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ (2020) Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol 13(1):4","journal-title":"J Hematol Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04618-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04618-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04618-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T13:11:04Z","timestamp":1690463464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04618-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["4618"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04618-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2218336\/v1","asserted-by":"object"}]},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"30 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies were approved by the Institutional Animal Care and Use Committee (IACUC) of Nanchang Royo Biotech Co., Ltd. (Permit RYE2022040301). The patient had signed the informed consent form, and the sample collection was approved by the medical ethics committee of the Second Affiliated Hospital of Nanchang University (Permit No. 2021012). Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Informed consent was obtained from the patient and his relatives.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}